October 09, 2014
Global Green, Inc. Hires Law Firm to Handle Petition to be Filed with SEC
TALLAHASSEE, Fla. – October 9, 2014 – Global Green, Inc. (GOGC: Pink Sheets), a green bio-pharmaceutical company, today announced that it has retained Snyderburn, Rishoi & Swann LLP, a law firm that will handle the petition to be filed with the Securities and Exchange Commission to challenge the Commission’s Order that suspended trading in the stock of Global Green, Inc. shares in the OTC Market.
Further, at this time, Global Green, Inc. is seeking another vaccine manufacturer and evaluating how to proceed with the studies on its patented Salmogenics vaccine. This will take time and negotiations and will put the schedule of the attempt at USDA approval for the vaccine behind by an estimated 18-24 months.
About Global Green, Inc.
Global Green, Inc. is a green bio-pharmaceutical company committed to identifying technology platforms and commercializing vaccines that contain natural organisms that are not genetically modified, utilizing pharmaceutical standards without the use of mercury. For more information, visitwww.globalgreeninc.com.
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties which include, among others, the inherent uncertainties associated with smaller reporting companies including, without limitation, other risks detailed from time to time in the Company’s periodic reports filed with the SEC.